Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Low-frequency Electrical Stimulation for Cognitive Enhancement in Atrial Fibrillation

NCT: NCT07063381 · ENROLLING_BY_INVITATION

NCT IDNCT07063381
StatusENROLLING_BY_INVITATION
Start Date2025-09-09
Completion2027-12-31

Brief Summary

Cognitive function in patients with atrial fibrillation (AF) is often impaired due to the complex influence of various factors (cerebral hypoperfusion, neurodegeneration, microemboli, hypertension, chronic inflammation). This leads to impairment of cognitive functions, including attention, memory, executive functions, and speed of information processing. The search for affordable and safe methods to maintain or improve cognitive function in this group of people is an urgent task of modern medicine. One of the promising approaches is percutaneous low-frequency electrical stimulation of the auricular branch of the vagus nerve (transcutaneous Vagus Nerve Stimulation - tVNS). The auricular (auricular) branch of the vagus nerve is a peripheral branch of the vagus nerve innervating the skin of the auricle in the area of the tragus and the inner part of the external auditory canal. The tVNS engages the sensory fibres of the vagus nerve and thus mimics the sensory input to the brainstem, forming the so-called auriculo-vagal afferent pathway. Since these fibres project directly to the nucleus of the solitary pathway (solitary tract), which, in turn, has direct and indirect projections to the nuclei providing noradrenergic, endorphinergic and serotoninergic fibres in various parts of the brain regulating systemic indices of cardiovascular, respiratory and immunological functions, the organism's response to stimulation of the auricular branch of the vagus nerve is systemic in nature. Stimulation of this nerve can modulate central nervous system (CNS) activity, affecting processes related to memory, attention and emotional state. Mechanisms of action of tVNS include modulation of parasympathetic activity, enhancement of neuroplasticity through increased expression of neurotrophic factors (e.g., BDNF), improvement of cerebral blood circulation, and regulation of neuroinflammation (reduction of proinflammatory cytokines).

Frequently Asked Questions

What is Low-frequency Electrical Stimulation for Cognitive Enhancement in Atrial Fibrillation?

Low-frequency Electrical Stimulation for Cognitive Enhancement in Atrial Fibrillation is a clinical trial registered under NCT07063381. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT07063381?

The current status of NCT07063381 (Low-frequency Electrical Stimulation for Cognitive Enhancement in Atrial Fibrillation) is: ENROLLING_BY_INVITATION.

When did Low-frequency Electrical Stimulation for Cognitive Enhancement in Atrial Fibrillation start?

Low-frequency Electrical Stimulation for Cognitive Enhancement in Atrial Fibrillation started on 2025-09-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.